Login
$ZVSA
$0.10 +$0.00 (3.83%) Close

Insider Transactions

What Zyversa Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 0 0

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Wolfe Peter Chief Financial Officer Dec 16 Grant / award · A +3,000 $2.88 +$8.64K 44,585
Wolfe Peter Chief Financial Officer Dec 12 Grant / award · A +41,585 — — 41,585
O'Connor Daniel Director Dec 12 Other Transaction · J +1,377,598 — — 1,377,598
Glover Steve C Chief Executive Officer Dec 12 Grant / award · A +43,847 — — 43,847
Glover Steve C Chief Executive Officer Dec 12 Grant / award · A +49,636 — — 49,636
Glover Steve C Chief Executive Officer Dec 12 Grant / award · A +85,442 — — 85,442
Glover Steve C Chief Executive Officer Dec 12 Grant / award · A +448,909 — — 448,909
LaBella Nicholas A. Jr. Chief Scientific Officer Dec 12 Grant / award · A +18,094 — — 18,094
Incon Co., Ltd. 10% owner Dec 12 Grant / award · A +1,497,199 — — 1,497,199
A.g.p. / Alliance Global Partners Corp. 10% owner Mar 08 Other Transaction · J −3,427 — — 446,843
A.g.p. / Alliance Global Partners Corp. 10% owner Feb 03 Other Transaction · J −49,730 — — 450,270
Larkspur Health Llc 10% owner Jan 06 Other Transaction · J +236,273 — — 236,273
Briones David S. Chief Financial Officer Jan 06 Other Transaction · J +10,752 — — 10,752
O'Connor Daniel Chief Executive Officer Jan 06 Other Transaction · J +42,005 — — 42,005

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support